SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-23-000040
Filing Date
2023-10-27
Accepted
2023-10-27 07:49:53
Documents
15
Period of Report
2023-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20231027.htm   iXBRL 8-K 45384
2 EX-99.1 abbv-20230930xexhibit991.htm EX-99.1 472871
7 abbvieimage1a53.jpg GRAPHIC 15145
  Complete submission text file 0001551152-23-000040.txt   804478

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20231027.xsd EX-101.SCH 4516
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20231027_def.xml EX-101.DEF 21119
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20231027_lab.xml EX-101.LAB 43816
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20231027_pre.xml EX-101.PRE 21960
9 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20231027_htm.xml XML 11146
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 231351995
SIC: 2834 Pharmaceutical Preparations